Cargando…
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease
Autores principales: | García-Muñoz, Rafael A., McConnell, Joseph, Morales, Victoria, Sanz, Raul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820718/ https://www.ncbi.nlm.nih.gov/pubmed/35017428 http://dx.doi.org/10.4103/1673-5374.332143 |
Ejemplares similares
-
Administration of pre/probiotics with conventional drug treatment in Alzheimer’s disease
por: Hort, Jakub, et al.
Publicado: (2019) -
Active Tumor-Targeting by Smart Nanocarriers: A Potential Promising Approach to Overcome the Hurdles of Conventional Cancer Treatments
por: Charkhat Gorgich, Enam Alhagh, et al.
Publicado: (2021) -
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
por: Chu, Siwei, et al.
Publicado: (2020) -
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
por: Kumar, Girish, et al.
Publicado: (2023) -
Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy
por: Zargar, Amin, et al.
Publicado: (2020)